Indian renal denervation catheter market to grow at 11% CAGR: Report
The renal denervation catheters market in India is expected to grow at a compound annual growth rate of around 11 per cent between 2024 and 2033, according to a report.
)
01:24 PM IST
The renal denervation catheters market in India is expected to grow at a compound annual growth rate of around 11 per cent between 2024 and 2033, according to a report on Thursday. The rising prevalence of hypertension in India has become a significant health concern, leading to serious health issues and increased mortality rates.Â
Renal denervation has been emerging as one of the potential solutions to address these challenges, particularly for resistant hypertension.
The report by GlobalData, a data and analytics company revealed that India's renal denervation catheter market is expected to reach around $2 million in 2033.
“The limited availability of therapeutic approaches for controlling resistant hypertension and preference for minimally invasive procedures are some of the factors driving the renal denervation catheters market in India," said Nandini Nagpal, Medical Devices Analyst at GlobalData.
"The complexity of conventional renal denervation procedures restricts their effectiveness and accessibility across a wide spectrum of patients. This underscores the necessity for more innovative therapies to address hypertension more effectively,” Nagpal added.
In December 2023, Medtronic introduced the Symplicity Spyral renal denervation system in India after receiving FDA approval. This system offers patients a new adjunct way of lowering blood pressure through a catheter-based approach.
It utilises radiofrequency and supplements medications and lifestyle changes to assist in blood pressure reduction.
It is claimed to be both safe and efficient, ensuring consistent blood pressure reductions for patients.
“Given the substantial burden of hypertension and the challenge of treatment-resistant cases in India, renal denervation offers a novel therapeutic approach," Nagpal said.
"With the ongoing advancements in medical technology, including catheter design and targeting precision, coupled with the country's evolving healthcare infrastructure, renal denervation could find a useful application in medical centers across India,” she noted.
Get Latest Business News, Stock Market Updates and Videos; Check your tax outgo through Income Tax Calculator and save money through our Personal Finance coverage. Check Business Breaking News Live on Zee Business Twitter and Facebook. Subscribe on YouTube.
RECOMMENDED STORIES
)
8th CPC Revised Pension Estimates: What can be revised pension for Level 2, 4, 6, 8 and 10 employees at 2.08 and 2.57 fitment factors in 8th Pay Commission?
)
7 Stocks to Buy for Long Term: Brokerages bullish on Delhivery, Gabriel India, JK Cement & more; note down targets
)
Gratuity Calculation: What will be your gratuity for Rs 65,000, Rs 75,000 and Rs 85,000 last-drawn basic salary after 9 years and 6 months of service?
)
Zomato CEO Deepinder Goyal Rs 52.3 Cr Flat at DLF Camellias: Here’s why it’s now valued nearly 3x higher
)
Power of Rs 13,000 SIP: How long will it take to turn Rs 13,000 monthly investment into Rs 5,00,00,000 corpus?
)
Stocks to Buy: These 6 large & midcap stocks may see strong upside soon – Top brokerages reveal buy calls & target prices
)
8th Pay Commission Pay Projections for Indian Army: What can be revised salary for Subedar Major, Captain and others at 2.08-2.57 fitment factors
01:24 PM IST